Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation

Nucleic Acids Research

Volumn 29, Issue 9, 2001, Pages 1989-1993

  Kaku, Shinsuke ^a   Iwahashi, Yuki ^a   Kuraishi, Aiko ^a   Albor, Amador ^b   Yamagishi, Takehiro ^a   Nakaike, Shiro ^a   Kulesz Martin, Molly ^b  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; INHIBITOR PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PAB421; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; RECOMBINANT PROTEIN; SPACER DNA; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CIP1 PROTEIN; CYCLINE; ONCOPROTEIN; PROTO ONCOGENE PROTEINS;

ACETYLATION; ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; GENE CONTROL; GENE SEQUENCE; GENE TARGETING; GENETIC CODE; GENETIC TRANSCRIPTION; GENOTOXICITY; GROWTH INHIBITION; MOLECULAR MIMICRY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN STABILITY; BINDING COMPETITION; CHEMISTRY; COMPARATIVE STUDY; GENE DELETION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE;

ANIMALIA;

BASE SEQUENCE; BINDING SITES; BINDING, COMPETITIVE; COMPARATIVE STUDY; CONSENSUS SEQUENCE; CYCLINS; HUMAN; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN P53; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; SEQUENCE DELETION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035341041     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.9.1989     Document Type: Article

References (15)

1. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
2. Fuchs, S.Y., Adler, V., Buschmann, T., Wu, X. and Ronai, Z. (1998) Mdm2 association with p53 targets its ubiquitination. Oncogene, 17, 2543-2547.
3. Honda, R. and Yasuda, H. (1999) Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J., 18, 22-27.
4. Wu, X.W., Bayle, J.H., Olson, D. and Levine, A.J. (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev., 7, 1126-1132.
5. El-Deiry, W.S., Kern, S.E., Pietenpol, J.A., Kinzler, K.W. and Vogelstein, B. (1992) Definition of a consensus binding site for p53. Nat. Genet., 1, 45-49.
6. Hupp, T.R., Meek, D.W., Midgley, C.A. and Lane, D.P. (1992) Regulation of the specific DNA binding function of p53. Cell, 71, 875-886.
7. Wu, Y., Liu, Y., Lee, L., Miner, Z. and Kulesz-Martin, M. (1994) Wild-type alternatively spliced p53: binding to DNA and interaction with the major p53 protein in vitro and in cells. EMBO J., 13, 4823-4830.
8. Hupp, T.R., Sparks, A. and Lane, D.P. (1995) Regulation of the specific DNA binding function of p53. Cell, 83, 237-245.
9. Funk, W.D., Pak, D.T., Karas, R.H., Wright, W.E. and Shay, J.W. (1992) A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol., 12, 2866-2871.
10. Giaccia, A.J. and Kastan, M.B. (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev., 12, 2973-2983.
11. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
12. Albor, A., Kaku, S. and Kulesz-Martin, M.F. (1998) Wild type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for the gain of function in mutants. Cancer Res., 58, 2091-2094.
13. Unger, T., Juven-Gershon, T., Moallem, E., Berger, M., Sionov, R.V., Lozano, G., Oren, M. and Haupt, Y. (1999) Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J., 18, 1805-1814.
14. Wang, P., Reed, M., Wang, Y., Mayr, G., Stenger, J.E., Anderson, M.E., Schwedes, J.F. and Tegtmeyer, P. (1994) p53 domains: structure, oligomerization, and transformation. Mol. Cell. Biol., 14, 5182-5191.
15. Stenger, J.E., Tegtmeyer, P., Mayr, G.A., Reed, M., Wang, Y., Wang, P., Hough, P.V. and Mastrangelo, I.A. (1994) p53 oligomerization and DNA looping are linked with transcriptional activation. EMBO J., 13, 6011-6020.